Gender Studies in medicine is a highly relevant societal topic. This is because gender plays an important role in both the development and treatment of diseases. Gender-specific differences are also evident in dementia patients. For example, women develop dementia more often than men and show a different...
The MAKS® therapy was honored with an MSD Health Award 2024. The MAKS® program, consisting of several components, has been proven to help people with mild to moderate dementia maintain their cognitive abilities for as long as possible. The non-pharmacological activation therapy helps to slow the progression of dementia and alleviate its symptoms. For the award...
Die sogenannte Amyloid-Hypothese hat die Alzheimerforschung über Jahrzehnte hinweg maßgeblich geprägt und zur Entwicklung der ersten Antikörpertherapien geführt. Trotz dieser Fortschritte bleiben die klinischen Erfolge begrenzt, was zunehmend Fragen zur Wirksamkeit und zum tatsächlichen Nutzen dieser Therapien aufwirft. In unserem Webinar hat Prof. Dr. Christian Behl, einer der international renommiertesten …
Echte Hilfe für Betroffene oder medialer Hype – was können wir von den neuen Medikamenten zur Behandlung der Alzheimer-Erkrankung wirklich erwarten? Weltweit führen Fachexperten kontroverse Diskussionen über die sogenannten monoklonalen Antikörper, die für die Behandlung von leichten kognitiven Beeinträchtigungen und Alzheimer-Demenz vorgesehen sind. Mit den Fakten aus der Forschung werden …
In the fourth edition of our new special newsletter SCHLAGLICHT – New Drugs for Dementia, Florian Weidinger, research associate at digiDEM Bayern, deals with the publication "The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer’s disease: an EADC-EC viewpoint" by the research team led by Professor Linus Jönsson from the Karolinska Institutet in Sweden. In the journal The Lancet…
At the 12th Congress of the German Alzheimer Society in the Stadthalle of Fürth/Bavaria, digiDEM Bavaria was not only represented with its own booth but also with a scientific symposium led by Prof. Dr. med. Elmar Gräßel, head of the Center for Medical Research at the University Hospital Erlangen and project manager of digiDEM…
A study from Portugal shows how caregivers and relatives of people with dementia can reduce burdens and improve quality of life. An important research finding: Those who can forgive reduce stress and lessen their perceived subjective burden. As the dementia progresses, the burdens on caregivers and relatives also increase. Caregivers…
Anxiety is very common in older adults and people with dementia. However, those who experience chronic or new-onset anxiety also have a higher risk of developing dementia. This connection is particularly strong in people under 70 years of age. Researchers from Australia discovered this. Do people…
Currently, more than 60 million people worldwide are affected by neurodegenerative diseases, such as Alzheimer's dementia. Researchers from Sichuan University in China and the Karolinska Institutet in Sweden have now investigated the connection between body composition (including body fat) and the risk of neurodegenerative diseases. The focus was not only on...
Researchers from the USA and Sweden investigated the risk of developing severe depression after an Alzheimer's diagnosis. More than four million people from Sweden participated in the study. Their findings were published in April 2024 in the renowned journal Alzheimer's & Dementia. If, with...
